Clinical Trial Update: An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis [Phase 1]

View source ↗

Summary

Completed Phase 1 open-label crossover trial comparing the relative bioavailability, efficacy and safety of Epanova and Lovaza in men and women with a history o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Epanova (icosapent ethyl)
• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Hypertriglyceridemia | Phase 1 | Status: COMPLETED | Results posted: 2016-06-20